Shazli N. Malik
- Molecular Biology top 10%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Jeffrey I. KreisbergRoble BedollaP. GhoshDean A. TroyerThomas J. PrihodaMichael G. BrattainAbhik BandyopadhyayFernando López‐Casillas
- Topics
- PI3K/AKT/mTOR signaling in cancer (3 papers)HER2/EGFR in Cancer Research (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Partner nations
- United StatesSwitzerlandMexico
In The Last Decade
Shazli N. Malik
16 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 801
- Oncology 411
- Pulmonary and Respiratory Medicine 400
- Cancer Research 232
- Pathology and Forensic Medicine 147
Countries citing papers authored by Shazli N. Malik
This map shows the geographic impact of Shazli N. Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shazli N. Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shazli N. Malik more than expected).
Fields of papers citing papers by Shazli N. Malik
This network shows the impact of papers produced by Shazli N. Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shazli N. Malik. The network helps show where Shazli N. Malik may publish in the future.
Co-authorship network of co-authors of Shazli N. Malik
This figure shows the co-authorship network connecting the top 25 collaborators of Shazli N. Malik. A scholar is included among the top collaborators of Shazli N. Malik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shazli N. Malik. Shazli N. Malik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 115 | |
| 3 | 262 | |
| 4 | 61 | |
| 5 | 51 | |
| 6 | 6 | |
| 7 | 69 | |
| 8 | Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients. | 104 |
| 9 | 69 | |
| 10 | Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. | 264 |
| 11 | Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft. | 114 |
| 12 | 12 | |
| 13 | 41 | |
| 14 | 34 | |
| 15 | 4 | |
| 16 | 25 |
About Shazli N. Malik
Shazli N. Malik is a scholar working on Oncology, Gastroenterology and Immunology and Allergy, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Cancer Research (232 citations), Oncology (411 citations) and Pulmonary and Respiratory Medicine (400 citations). Shazli N. Malik has collaborated with scholars based in United States, Switzerland and Mexico. Frequent co-authors include Jeffrey I. Kreisberg, Roble Bedolla, P. Ghosh, Dean A. Troyer, Thomas J. Prihoda, Michael G. Brattain, Abhik Bandyopadhyay, Fernando López‐Casillas, William M. Murphy and Valentı́n Mendoza. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.